Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India with a point-of-care testing platform

The Accula System is an innovative platform that will accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care.

Mumbai (Maharashtra) [India], June 15: Thermo Fisher Scientific today announced the introduction of the new and innovative Accula SARS-CoV-2 Test that delivers gold-standard reverse transcription-polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format.

The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for the detection of SARS-CoV-2 in Clinical Laboratory Improvement Amendments (CLIA)–waived environments.

“Since the start of the pandemic, Thermo Fisher has acted quickly to provide support to the scientists and healthcare professionals at the frontlines of combating COVID-19,” said Amit Chopra, Managing Director, India, and South Asia, Thermo Fisher Scientific. “Thermo Fisher’s new testing platform combines the accuracy of RT-PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula SARS-CoV-2 Test is a natural extension to our existing offerings and will significantly help to meet the continuing demands for rapid and reliable COVID-19 testing in India.”

RT-PCR testing is streamlined from start to finish using a fully integrated, single-use microfluidic test cassette and the reusable, palm-sized Accula Dock. The test uses nasal swab samples and provides reliable, qualitative results in approximately 30 minutes. The Accula SARS-CoV-2 Test is enabled by proprietary PCR technology that allows for reduced absolute temperatures and reduced temperature differentials—resulting in rapid exponential amplification while reducing overall thermocycling times.

“The rapid Accula point-of-care test will open new avenues of personal and public testing without compromising on accuracy,” added Amit. “The introduction of the test in India is a demonstration of the impact our solutions have on human health during the pandemic, and far beyond.”

In January 2021, Thermo Fisher acquired Mesa Biotech Inc., which developed the Accula SARS-CoV-2 Test to provide accurate and faster results at the point of care.

For more information, please visit www.thermofisher.com

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon.

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

NEURIA – an App to Improve the Quality of Mental Health and Treatment of Neurological Patients and their Caregivers launched in India

Pune (Maharashtra) [India], January 20: NEURIA, a free mobile application developed by Innoplexus A.G., helping millions of people all over the world with their mental health problems and treatment guidance, has now been launched in India. We live in a digital world, and there is access to any kind of information at your fingertips, courtesy […]

Read More
Health

Morbid obesity must be considered as the top public health priority in India-Shree Skincare & Slimming Center

Yamuna Nagar (Haryana) [India], January 19: With obesity in India reaching epidemic proportions in the 21st century and morbid obesity affecting about 5% of the country’s population, experts have called for accommodating obesity as the public health priority. Dr. Pratayksha Bharadwaj, a research member of the Indian Obesity Network (ION) and the World Obesity Organisation […]

Read More
Health

Meadbery steps in to promote plant-based supplements for a better health

January 17: Meadbery offers plant-based, gluten-free, Non-Gmo, and sugar-free products that help in sustainable living. With extensive years of research, Meadbery has found out effective formulas for Nutraceutical products that have the potential of preventing diseases. Developed in Dallas-Texas, USA, Meadbery manufactures its products in a WHO-GMP Manufacturing facility in India using 100% Organic ingredients […]

Read More